These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

838 related items for PubMed ID: 24315973

  • 21. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C, Sperb A, Sudarski S, Lossnitzer D, Rudic B, Tülümen E, Heggemann F, Schimpf R, Schoenberg SO, Borggrefe M, Papavassiliu T.
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [Abstract] [Full Text] [Related]

  • 22. Prognostic impact of combined late gadolinium enhancement on cardiovascular magnetic resonance and peak oxygen consumption in ambulatory patients with nonischemic dilated cardiomyopathy.
    Yamada T, Hirashiki A, Okumura T, Adachi S, Shimazu S, Shimizu S, Morimoto R, Takeshita K, Naganawa S, Kondo T, Murohara T.
    J Card Fail; 2014 Nov; 20(11):825-32. PubMed ID: 25151210
    [Abstract] [Full Text] [Related]

  • 23. Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy.
    Nojiri A, Hongo K, Kawai M, Komukai K, Sakuma T, Taniguchi I, Yoshimura M.
    J Cardiol; 2011 Nov; 58(3):253-60. PubMed ID: 21890327
    [Abstract] [Full Text] [Related]

  • 24. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S, Puchalski MD, Everitt MD, Williams RV, Weng HY, Menon SC.
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [Abstract] [Full Text] [Related]

  • 25. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy.
    Latus H, Gummel K, Klingel K, Moysich A, Khalil M, Mazhari N, Bauer J, Kandolf R, Schranz D, Apitz C.
    J Cardiovasc Magn Reson; 2015 May 15; 17(1):34. PubMed ID: 25976093
    [Abstract] [Full Text] [Related]

  • 26. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L, Xu HY, Zheng SS, Zhu Y, Xiao JX, Zhou W, Yu SS, Gong LG.
    Int J Cardiovasc Imaging; 2017 Dec 15; 33(12):1949-1959. PubMed ID: 28612277
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
    Funada A, Kanzaki H, Noguchi T, Morita Y, Sugano Y, Ohara T, Hasegawa T, Hashimura H, Ishibashi-Ueda H, Kitakaze M, Yasuda S, Ogawa H, Anzai T.
    Heart Vessels; 2016 May 15; 31(5):758-70. PubMed ID: 25820658
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging.
    Gao P, Yee R, Gula L, Krahn AD, Skanes A, Leong-Sit P, Klein GJ, Stirrat J, Fine N, Pallaveshi L, Wisenberg G, Thompson TR, Prato F, Drangova M, White JA.
    Circ Cardiovasc Imaging; 2012 Jul 15; 5(4):448-56. PubMed ID: 22572740
    [Abstract] [Full Text] [Related]

  • 32. Late gadolinium enhancement of cardiac magnetic resonance imaging indicates abnormalities of time-domain T-wave alternans in hypertrophic cardiomyopathy with ventricular tachycardia.
    Sakamoto N, Sato N, Oikawa K, Karim Talib A, Sugiyama E, Minoshima A, Tanabe Y, Takeuchi T, Akasaka K, Saijo Y, Kawamura Y, Hasebe N.
    Heart Rhythm; 2015 Aug 15; 12(8):1747-55. PubMed ID: 25916568
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy.
    Almaas VM, Haugaa KH, Strøm EH, Scott H, Smith HJ, Dahl CP, Geiran OR, Endresen K, Aakhus S, Amlie JP, Edvardsen T.
    Heart; 2014 Apr 15; 100(8):631-8. PubMed ID: 24368281
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.
    Lyons KS, Dixon LJ, Johnston N, Noad R, Hamilton A, McKeag N, Horan P.
    Cardiol J; 2014 Apr 15; 21(1):29-32. PubMed ID: 23990187
    [Abstract] [Full Text] [Related]

  • 40. Frequency and distribution of late gadolinium enhancement in magnetic resonance imaging of patients with apical hypertrophic cardiomyopathy and patients with asymmetrical hypertrophic cardiomyopathy: a comparative study.
    Yamada M, Teraoka K, Kawade M, Hirano M, Yamashina A.
    Int J Cardiovasc Imaging; 2009 Apr 15; 25 Suppl 1():131-8. PubMed ID: 19165622
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.